As shown in Fig 4A DC-based HHP lung cancer vaccine stimulated the expansion of MP158-66-specific CD8+ T cells over iDC or DC treated with poly(I:C) alone which proves that protein antigens from HHP-killed lung cancer cells are processed and presented by DC to T cells. This evidence concerns the gene CD8A and lung cancer.